HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joop D Lefrandt Selected Research

Syntex adjuvant formulation

12/2017Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm.
1/2016Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
6/2015Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease.
4/2014Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
1/2013Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
2/2012Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.
2/2011Dermal factors influencing measurement of skin autofluorescence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joop D Lefrandt Research Topics

Disease

10Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 01/2013
8Testicular Neoplasms (Testicular Cancer)
12/2023 - 02/2016
8Type 2 Diabetes Mellitus (MODY)
01/2021 - 09/2010
7Peripheral Arterial Disease
12/2017 - 01/2013
6Thyroid Neoplasms (Thyroid Cancer)
01/2023 - 12/2015
5Insulin Resistance
11/2020 - 09/2010
5Atherosclerosis
01/2017 - 02/2012
4Neoplasms (Cancer)
01/2021 - 09/2010
3Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2023 - 11/2015
3Hypothyroidism
01/2023 - 01/2020
3Breast Neoplasms (Breast Cancer)
12/2022 - 09/2010
3Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 02/2015
3Inflammation (Inflammations)
01/2016 - 01/2010
3Diabetes Mellitus
06/2015 - 02/2012
2Hypogonadism (Hypergonadotropic Hypogonadism)
12/2023 - 11/2021
2Thrombosis (Thrombus)
01/2023 - 11/2010
2Body Weight (Weight, Body)
11/2020 - 01/2017
2Heart Failure
01/2020 - 03/2003
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2017 - 01/2013
2Abdominal Aortic Aneurysm
12/2017 - 01/2013
2Myocardial Infarction
04/2016 - 04/2014
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2015 - 01/2013
2Stroke (Strokes)
04/2014 - 11/2010
2Carotid Stenosis (Carotid Artery Stenosis)
02/2012 - 11/2010
1Pneumonia (Pneumonitis)
12/2023
1Hyperthyroidism
01/2023
1Hemorrhage
01/2023
1Dyslipidemias (Dyslipidemia)
12/2022
1Fatigue
11/2022
1Cognitive Dysfunction
11/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
11/2020
1Ovarian Epithelial Carcinoma
10/2020
1Arteritis
11/2019
1Non-alcoholic Fatty Liver Disease
11/2019
1Hypotension (Low Blood Pressure)
01/2018
1Hypertension (High Blood Pressure)
12/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2017
1Overweight
12/2017
1Multiple Organ Failure (MODS)
01/2016
1Critical Illness (Critically Ill)
01/2016
1Atrial Fibrillation
12/2015
1Chronic Limb-Threatening Ischemia
06/2015
1Pregnancy Complications
01/2013
1Chronic Renal Insufficiency
01/2013

Drug/Important Bio-Agent (IBA)

12Advanced Glycation End ProductsIBA
12/2022 - 01/2009
7Syntex adjuvant formulationIBA
12/2017 - 02/2011
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2011
5Biomarkers (Surrogate Marker)IBA
01/2017 - 11/2010
4Cisplatin (Platino)FDA LinkGeneric
12/2023 - 10/2016
4C-Reactive ProteinIBA
11/2019 - 08/2015
3Thyroid HormonesIBA
01/2023 - 01/2020
3CholesterolIBA
11/2020 - 01/2017
3AdiponectinIBA
11/2019 - 08/2014
3LipidsIBA
12/2017 - 01/2010
3BilirubinIBA
11/2015 - 08/2014
2Triglycerides (Triacylglycerol)IBA
12/2023 - 09/2011
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2009
2Hormones (Hormone)IBA
12/2022 - 02/2016
2Testosterone (Sustanon)FDA Link
11/2021 - 02/2016
2Metformin (Glucophage)FDA LinkGeneric
10/2020 - 09/2010
2HDL CholesterolIBA
01/2020 - 09/2011
2Lipoproteins (Lipoprotein)IBA
01/2020 - 11/2014
2Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2020 - 09/2011
2LeptinIBA
11/2019 - 08/2015
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2017 - 08/2016
1Etoposide (VP 16)FDA LinkGeneric
12/2023
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2023
1Hemostatics (Antihemorrhagics)IBA
01/2023
1Aromatase InhibitorsIBA
12/2022
1FluorineIBA
01/2021
1PlatinumIBA
01/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
11/2020
1Branched-Chain Amino AcidsIBA
11/2020
1tyramine-deoxysorbitolIBA
10/2020
1Carboplatin (JM8)FDA LinkGeneric
10/2020
1Paclitaxel (Taxol)FDA LinkGeneric
10/2020
1HDL LipoproteinsIBA
01/2020
1AnthracyclinesIBA
01/2020
1N-(3,4,5-trichlorophenyl)succinimideIBA
12/2017
1pro-brain natriuretic peptide (1-76)IBA
08/2017
1LinagliptinIBA
01/2017
1AndrogensIBA
02/2016
1Lysine (L-Lysine)FDA Link
01/2016
1N(6)-carboxymethyllysine (carboxymethyllysine)IBA
01/2016
1Glycoproteins (Glycoprotein)IBA
11/2015
1oxidized low density lipoproteinIBA
11/2014
1omega-Chloroacetophenone (Mace)IBA
04/2014
1Indicators and Reagents (Reagents)IBA
02/2012

Therapy/Procedure

10Drug Therapy (Chemotherapy)
12/2023 - 02/2016
5Therapeutics
01/2023 - 04/2016
3Aftercare (After-Treatment)
11/2021 - 12/2015
3Thyroidectomy
11/2020 - 12/2015
2Salpingo-oophorectomy
01/2017 - 02/2015
2Glycemic Control
09/2015 - 01/2013
1Combination Drug Therapy (Combination Chemotherapy)
12/2023
1Renal Dialysis (Hemodialysis)
01/2018
1Surgical Amputation (Amputations)
06/2015
1Secondary Prevention
01/2013